Read the Beforeitsnews.com story here. Advertise at Before It's News here.

By culrav
Contributor profile | More stories

Story Views
Now:
Last hour:
Last 24 hours:
Total:

Pain Management Therapeutics Market: Global Industry Size, Share, Trends, Growth Drivers, Strategic Analysis and Forecast Report to 2017 Available at ResearchMoz.us

Friday, May 17, 2013 9:25

% of readers think this story is Fact. Add your two cents.

This Press Release Distributed By CULRAV.ORG http://www.culrav.org

ResearchMoz.us include new market research report”Pain Management Therapeutics Market to 2017 – Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta ” to its huge collection of research reports.

Pain Management Therapeutics Market to 2017 – Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta, which provides insights into the global pain management therapeutics market and market forecasts until 2017. The report provides an in-depth analysis of the top eight therapeutic indications for which pain management drugs are often prescribed, which includes fibromyalgia, neuropathic pain, migraine, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post-operative pain. The report also examines the global pain management therapeutics treatment usage patterns for the covered indications. In addition, the report also includes insights into the pain management therapeutics R&D pipeline.

VIEW FULL REPORT WITH TOC: http://www.researchmoz.us/pain-management-therapeutics-market-to-2017-price-competition-to-intensify-following-patent-expiries-of-lyrica-and-cymbalta-report.html

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts.

The global pain management therapeutics market has huge potential for growth due to the large population that is affected by medically significant pain. The market is growing at a moderate growth rate, driven by the cancer pain, low back pain and post-operative pain relief markets. In 2010, the global pain management therapeutics market was estimated at $28.6 billion, representing a CAGR of 5.3% between 2002 and 2010. The post-operative pain relief market, with sales of $5.9 billion in 2010, accounted for one fifth of the total pain management therapeutics market. The low back pain market, with sales of $4.9 billion, was the second largest market segment, with a share of 17% of the worldwide pain management therapeutics market. The low back pain market is followed by the cancer pain and neuropathic pain relief markets, accounting for 16% each of the global pain management therapeutics market.

Buy a copy of this report@ http://www.researchmoz.us/sample/checkout.php?rep_id=25957&type=S

The global pain management market is driven by anticonvulsant Lyrica and anti-depressant Cymbalta, which are expected to expire in 2013. By 2017, the global pain management therapeutics market is forecast to generate sales of $35.1 billion, representing a CAGR of 3.0% between 2010 and 2017. Other blockbuster drugs that are likely to drive the market in the forecast period include UCB Groups Vimpat (lacosamide), Tevas Fentora (fentanyl), J&Js Nucynta (tapentadol), Pfizers Remoxy (oxycodone hydrochloride) and Orexos Abstral (fentanyl).

Scope

Data and analysis on the pain therapeutics market in the leading geographies of the world the US, the UK, Germany, France, Italy, Spain, and Japan.
Annualized market data for the pain management therapeutics market from 2002 to 2010, with forecasts to 2017.
Market data on the therapeutic landscape, which covers fibromyalgia, neuropathic pain, migraine, cancer pain, osteoarthritis pain, rheumatoid arthritis pain, low back pain and post-operative pain therapeutics, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population and treated population.
Key drivers and restraints that have had a significant impact on the market and on each indication.
The competitive landscape of the global pain management therapeutics market, which includes companies such as Pfizer, Johnson & Johnson, Teva, Eli Lilly and several mid-size players such as Purdue Pharma, Endo Pharmaceuticals, and Forest Laboratories.
Key M&A activities and Licensing Agreements that took place from 2005 to 2010 in the global pain management therapeutics market.

Reasons to buy

Align your product portfolio to the markets with high growth potential.
Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
Devise a more tailored country strategy through the understanding of key drivers and barriers of the regions pain management therapeutics market.
Develop key strategic initiatives by understanding the key focus areas and top selling pain management therapeutics molecules of leading companies.
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

####

Related Report:

The Future of Pain Management Therapeutics, Analysis and Market (http://www.researchmoz.us/the-future-of-pain-management-therapeutics-analysis-and-market-forecasts-to-2016-increasing-generic-competition-creates-challenges-report.html) Forecasts to 2016 – Increasing Generic Competition Creates Challenges”. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global pain management therapeutics market. The report analyzes the markets for pain management in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

About Us:

ResearchMoz (http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.

For More Information Kindly Contact:

Email: [email protected]

Visit: http://technoviamarketresearchreports.blogspot.com

Source: http://www.culrav.org/pr/pain-management-therapeutics-market-global-industry-size-share-trends-growth-drivers-strategic-analysis-and-forecast-report-to-2017-available-at-researchmoz-us.php

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Lion’s Mane Mushroom

Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.

Our Formula includes:

Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.

Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.

Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.

Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.

Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.

Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.

Comments

Online:
Visits:	1,609,573,705
Stories:	8,168,102